RIBONUCLEOTIDE REDUCTASE AS TARGET FOR EN ZYME-DIRECTED CHEMOTHERAPY-EFFECTS OF TRIMIDOX (3,4,5-TRIHYDROXYBENZOHYDROXIME), A NEW INHIBITOR OF RIBONUCLEOTIDE REDUCTASE
G. Findenig et al., RIBONUCLEOTIDE REDUCTASE AS TARGET FOR EN ZYME-DIRECTED CHEMOTHERAPY-EFFECTS OF TRIMIDOX (3,4,5-TRIHYDROXYBENZOHYDROXIME), A NEW INHIBITOR OF RIBONUCLEOTIDE REDUCTASE, Wiener Klinische Wochenschrift, 107(22), 1995, pp. 694-697
Inhibition of the enzyme ribonucleotide reductase by polyhydroxy-subst
ituted benzohydroxamide derivates is an example for the effects of ant
imetabolites. We present an overview of the effects of antimetabolites
, in particular regarding their action on leukemia cells, Trimidox is
one of the most effective inhibitors of ribonucleotide reductase. It i
nhibits the enzyme in cell extracts as well as in the in situ assay an
d causes decreased dGTP and dCTP pools in KL-60 cells. We describe com
binations with other antimetabolites, as well as biochemical, morpholo
gical and cytotoxic effects of trimidox. This manuscript gives an over
view of our results with trimidox and describes selection criteria, ef
fects and combinations used in enzyme-targeted chemotherapy.